DSM-Firmenich AG
OTC:DSMFF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DSM-Firmenich AG
OTC:DSMFF
|
CH |
|
M
|
Medifast Inc
DUS:MDF
|
US |
|
Ascencio SCA
LSE:0P2J
|
BE |
|
C
|
Ciena Corp
LSE:0HYA
|
US |
|
BCE Inc
TSX:BCE
|
CA |
|
C
|
Carabao Group PCL
SET:CBG
|
TH |
|
F
|
Fennec Pharmaceuticals Inc
TSX:FRX
|
US |
|
Smith & Nephew PLC
F:NPWA
|
UK |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
F
|
Fennec Pharmaceuticals Inc
SWB:RV41
|
US |
|
C
|
China Industrial Group Inc
OTC:CIND
|
US |
|
Nien Made Enterprise Co Ltd
TWSE:8464
|
TW |
Wall St Price Targets
DSMFF Price Targets Summary
DSM-Firmenich AG
According to Wall Street analysts, the average 1-year price target for DSMFF is 109.8 USD with a low forecast of 78.53 USD and a high forecast of 129.17 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DSMFF's stock price target?
Price Target
109.8
USD
According to Wall Street analysts, the average 1-year price target for DSMFF is 109.8 USD with a low forecast of 78.53 USD and a high forecast of 129.17 USD.
What is the Revenue forecast for DSM-Firmenich AG?
Projected CAGR
6%
Over the last 3 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for DSM-Firmenich AG?
Projected CAGR
7%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for DSM-Firmenich AG?
Projected CAGR
23%
Over the last 3 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 23%.
What is the Pre-Tax Income forecast for DSM-Firmenich AG?
Projected CAGR
25%
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 25%.